As a result, the latest statistics from Seer suggest that thyroid cancer cases have now stabilised in the US. For example, in 2010 there were on average 13.9 new cases per 100,000, while in 2022 – the last year for which statistics are available – there were 14.1 cases per 100,000.

A new study reveals eating ultraprocessed foods increases early-onset colorectal cancer risk by 45%. Research links ready-to-eat foods to precancerous adenomas.

The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won't change how they counsel patients.

Women who ate the most ultra-processed foods – 10 servings per day on average – had a 45% higher risk of developing pre-cancerous polyps in their colon, compared to women who ate three servings a day on average.

A laboratory study reveals an interaction between dietary fiber and the gut microbiome that may be helpful for fighting cancer.

Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy found shocking results: There was a tumor in his lung that was crushing the left side of his windpipe, causing the coughing and pain.

Johnson & Johnson has agreed to buy privately held cancer drugmaker Halda Therapeutics for $3bn in the latest hotly contested pursuit of a biotech. The deal comes amid a flurry of biotech buyouts as big pharma groups seek to offset potential losses from expiring patents on blockbuster drugs.

Johnson & Johnson said on Monday it would buy privately held Halda Therapeutics for $3.05 billion in cash, expanding its presence in treatments targeting solid tumors and prostate cancer. This marks the medtech conglomerate's second major deal this year,